DALLAS, July 6, 2016 /PRNewswire/ -- Aprima Medical Software announced today that the Aprima EHR/PM platform is compliant to help practices earn incentives based on the currently proposed rules for Medicare's Merit-Based Incentive Payment System (MIPS). MIPS is a proposed quality-based performance program created as part of the Medicare Access and CHIP Reauthorization Act (MACRA) and is designed to reward physicians for providing high quality care.
The proposed MIPS program allows Eligible Professionals to earn positive payment adjustments on Medicare Part B payments of up to 4% in 2019 and up to 9% in 2022 and beyond. Low performing clinicians will be subject to negative payment adjustments ranging from 4% in 2019 and 9% in 2022 and beyond. Performance level assessment will begin in 2017 and be the basis for the 2019 payment adjustments. By utilizing a MIPS-ready solution like Aprima, providers are better positioned to earn incentives at the maximum levels.
"Based on our understanding of the current proposed rule, we believe Aprima meets all the necessary criteria to help practices achieve MACRA success," said Michael Nissenbaum, president and CEO of Aprima. "We will obviously re-evaluate our capabilities once the final rule is released this fall, but currently our solution aligns beautifully with the proposed MIPS program."
MIPS is designed to improve the relevance and depth of Medicare's value and quality-based payments and increase clinician flexibility by allowing providers to choose measures and activities appropriate to the type of care they provide. It combines parts of the Physician Quality Reporting System (PQRS), the Value Modifier (VM) and the Medicare EHR incentive program into a single program that measures quality, resource use, clinical practice improvement and the Meaningful Use of certified EHR technology.
"Because Aprima is already certified for Meaningful Use Stage 2, meets the quality objectives for PQRS and is NCQA Prevalidated for PCMH, we are confident that our customers will be well-positioned to exceed the composite performance score requirements to earn incentives under the proposed MIPS program," said Neil Simon, COO of Aprima. "Regardless of what CMS includes in the final rule, Aprima will continue to align its solutions to equip customers with the functionality they need for financial and clinical success."
The proposed rule is designed to improve the relevance and depth of Medicare's value and quality-based payments and increase clinician flexibility by allowing clinicians to choose measures and activities appropriate to the type of care they provide. MIPS allows Medicare clinicians to be paid for providing high quality, efficient care through success in four performance categories, including quality measures, resource use, clinical practice improvement activities and the meaningful use of an EHR.
About Aprima Medical Software, Inc.
Aprima provides innovative electronic health record, practice management and revenue cycle management solutions for medical practices. The Aprima EHR/PM is an integrated system built on a single database. Aprima uses a fast, flexible design that adapts automatically to a physician's workflow and sets the benchmark for ease-of-use, speed and flexibility. Aprima is one of the few companies with an 18-year track record of success, including Certification for Meaningful Use Stage 2. Thousands of Aprima users are benefiting from improved quality of care, improved patient satisfaction, improved quality of life and an improved bottom line. Based in Carrollton, TX, Aprima performs all development, support and implementation from the U.S. To learn more about how Aprima can help your practice, please visit www.aprima.com, call us at 866 4APRIMA or email us at email@example.com.
Aprima is a registered trademark of Aprima Medical Software. All other trademarks are the property of their respective owners.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/aprima-ehrpm-platform-is-macramips-ready-300294662.html
SOURCE Aprima Medical Software, Inc.